We are live on ! Find out more
CADL icon

Candel Therapeutics
CADL

114 hedge funds and large institutions have $213M invested in Candel Therapeutics in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 8

147% more call options, than puts

Call options by funds: $2.14M | Put options by funds: $869K

82% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 22

59% more capital invested

Capital invested by funds: $134M → $213M (+$79.4M)

36% more funds holding

Funds holding: 84 → 114 (+30)

16.24% more ownership

Funds ownership: 43.05% → 59.29% (+16%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
114
Holders Change
+30
Holders Change %
+35.71%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
40
Reduced
22
Closed
8
Calls
$2.14M
Puts
$869K
Net Calls
+$1.27M
Net Calls Change
-$205K

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$34.9M
2
SVCM
Saturn V Capital Management
Texas
+$15.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$15M
4
PCM
Portolan Capital Management
Massachusetts
+$6.52M
5
VPC
Vestal Point Capital
New York
+$6.12M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$836K
2
Focus Partners Wealth
Focus Partners Wealth
Massachusetts
-$462K
3
Morgan Stanley
Morgan Stanley
New York
-$413K
4
Barclays
Barclays
United Kingdom
-$314K
5
Wells Fargo
Wells Fargo
California
-$312K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$668K +$223K +41,058 +43%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$554K -$133K -24,435 -18%
Charles Schwab
28
Charles Schwab
California
$547K -$50.5K -9,288 -8%
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$525K +$583K +107,211 New
SCM
30
Stonepine Capital Management
Oregon
$502K +$558K +102,500 New
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$467K +$71K +13,049 +16%
Two Sigma Investments
32
Two Sigma Investments
New York
$458K -$31K -5,700 -6%
N
33
Nuveen
North Carolina
$456K +$3.68K +676 +0.7%
KCM
34
Kennedy Capital Management
Missouri
$454K +$504K +92,625 New
AllianceBernstein
35
AllianceBernstein
Tennessee
$390K – – –
BCM
36
Bridgeway Capital Management
Texas
$368K +$109K +20,000 +36%
Citadel Advisors
37
Citadel Advisors
Florida
$356K -$836K -153,690 -68%
HWM
38
HB Wealth Management
Georgia
$330K +$48.4K +8,900 +15%
TGIA
39
Torrey Growth & Income Advisors
California
$318K +$2.17K +398 +0.6%
Lido Advisors
40
Lido Advisors
California
$295K +$305 +56 +0.1%
BC
41
Birchview Capital
Vermont
$294K – – –
AA
42
ALPS Advisors
Colorado
$292K +$79.2K +14,550 +32%
Hudson Bay Capital Management
43
Hudson Bay Capital Management
Connecticut
$290K +$322K +59,210 New
Morgan Stanley
44
Morgan Stanley
New York
$285K -$413K -75,802 -57%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$252K +$2.14K +394 +0.8%
Bank of America
46
Bank of America
North Carolina
$232K -$21.1K -3,880 -8%
BAM
47
Belpointe Asset Management
Nevada
$223K +$248K +45,604 New
MAM
48
Martingale Asset Management
Massachusetts
$215K +$34.8K +6,390 +17%
XT
49
XTX Topco
Cayman Islands
$214K +$109K +19,987 +84%
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$212K +$235K +43,208 New
1
2
3 4 5

CADL Hedge Fund Activity: Q1 2026 in Review

114 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Candel Therapeutics (CADL) for Q1 2026, worth a combined $213M — up 59% from $134M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CADL positions and 8 closed out — a net gain of 31 holders — while 40 added to existing stakes and 22 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $34.9M. The largest seller was Citadel Advisors, cutting an estimated $836K.

  • 114 institutional investors held Candel Therapeutics (CADL) as of Q1 2026, up from 84 in Q4 2025.
  • Funds reported $213M of Candel Therapeutics stock for Q1 2026, up 59% quarter-over-quarter.
  • 39 funds opened new Candel Therapeutics positions in Q1 2026 and 8 closed out, a net change of +31 holders.
  • The largest Candel Therapeutics buyer in Q1 2026 was RTW Investments, an estimated $34.9M added.
  • The largest Candel Therapeutics seller in Q1 2026 was Citadel Advisors, an estimated $836K sold.

Based on aggregated 13F filings for Q1 2026.